Haas Jason

Ligand Pharmaceuticals Incorporated · Director

Haas Jason is listed in public filings as director. This Haas Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Ligand Pharmaceuticals Incorporated (LGND), and Syros Pharmaceuticals, Inc. (SYRS). Investors use Haas Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Ligand Pharmaceuticals IncorporatedLGND$886k3.5k sharesSellJun 12, 2026$256.08$253.25
Ligand Pharmaceuticals IncorporatedLGND$765k3k sharesSellJun 12, 2026$255.01$253.25